BIOMAT Database Logo BIOMAT Database Logo

[Utilization of the method of immunological tolerance for inhibition of antibody formation to tissue antigens]. 1960

V I GEL'SHTEIN, and V N STEPINA

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

V I GEL'SHTEIN, and V N STEPINA
Criteria of immunological tolerance to tissue antigens.
January 1967, Clinical and experimental immunology,
V I GEL'SHTEIN, and V N STEPINA
[Immunological tolerance and inhibition of antibody formation by antigen (author's transl)].
May 1975, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
V I GEL'SHTEIN, and V N STEPINA
[Research on antitissue antibodies. The immunological tolerance to tissue antigens].
May 1962, Annales pharmaceutiques francaises,
V I GEL'SHTEIN, and V N STEPINA
THE INDUCTION OF IMMUNOLOGICAL TOLERANCE AFTER SPECIFIC ANTIBODY FORMATION.
November 1964, Annals of the New York Academy of Sciences,
V I GEL'SHTEIN, and V N STEPINA
Immunological tolerance to microbial antigens. II. Suppressed antibody plaque formation to Shigella antigen by spleen cells from tolerant mice.
October 1966, Journal of bacteriology,
V I GEL'SHTEIN, and V N STEPINA
[The reasons for the formation of tolerance to food antigens].
January 2023, Voprosy pitaniia,
V I GEL'SHTEIN, and V N STEPINA
Rh antigens and immunological tolerance.
June 1957, Nature,
V I GEL'SHTEIN, and V N STEPINA
[Some aspects of immunological tolerance for definite antigens].
March 1961, Annales de l'Institut Pasteur,
V I GEL'SHTEIN, and V N STEPINA
Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production.
March 1979, Proceedings of the National Academy of Sciences of the United States of America,
V I GEL'SHTEIN, and V N STEPINA
Signal minus 1: a key factor in immunological tolerance to tissue-specific self antigens?
June 1996, Immunology and cell biology,
Copied contents to your clipboard!